The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)
AJ Kerr, MJA Williams, S Harding , H White, RN Doughty, C Nunn, G Devlin, C Grey, M Lee, C Flynn, M Rhodes, K Sutherland, S Wells, RT Jackson, RAH Stewart, on behalf of the ANZACS-QI investigators
There is a formidable evidence base supporting the use of a range of lifestyle, pharmaceutical and interventional treatments to improve outcomes in patients with heart attacks. However, in practice, there is often a substantial gap between ideal treatment based on clinical trials and what is achieved in practice. The identification of these evidence-practice gaps, and the implementation of programmes to close them, represent an important opportunity to improve the outcomes of patients with CVD in New Zealand. The All New Zealand Acute Coronary Syndrome Quality Improvement programme (ANZACS-QI) has recently been implemented in 41 NZ public hospitals to support appropriate, evidence based management of ACS and subsequently of other cardiac patients regardless of age, sex, ethnicity, socioeconomic status, or rural or city dwelling. In this report we describe the development and national implementation of ANZACS-QI, its governance, the data collection processes and the current ANZACS-QI cohorts and available results.